177 related articles for article (PubMed ID: 37640409)
1. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult.
Sun G; Weiss A; Zhao J; Silver M; DeMaio M; Dehbashi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37640409
[TBL] [Abstract][Full Text] [Related]
2. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
3. Fatal mucormycosis and aspergillosis coinfection associated with haemophagocytic lymphohistiocytosis: A case report and literature review.
Loubet D; Sarton B; Lelièvre L; Grouteau G; Iriart X; Chauvin P; Fillaux J; Valentin A; Berry A; Silva S; Bonneville F; Cassaing S; Guemas E
J Mycol Med; 2023 Mar; 33(1):101325. PubMed ID: 36270214
[TBL] [Abstract][Full Text] [Related]
4. [Coinfection of rhinocerebral mucormycosis and sinus aspergillosis].
Torres-Damas W; Yumpo-Cárdenas D; Mota-Anaya E
Rev Peru Med Exp Salud Publica; 2015 Oct; 32(4):813-7. PubMed ID: 26732934
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
6. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
7. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
[TBL] [Abstract][Full Text] [Related]
8. Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient.
Hu ZM; Wang LL; Zou L; Chen ZJ; Yi Y; Meng QB; Feng Y
Braz J Microbiol; 2021 Dec; 52(4):2063-2068. PubMed ID: 34218427
[TBL] [Abstract][Full Text] [Related]
9. Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.
Chermetz M; Gobbo M; Rupel K; Ottaviani G; Tirelli G; Bussani R; Luzzati R; Di Lenarda R; Biasotto M
Mycopathologia; 2016 Oct; 181(9-10):723-33. PubMed ID: 27350324
[TBL] [Abstract][Full Text] [Related]
10. Dual Disseminated Aspergillosis and Mucormycosis Diagnosed at Autopsy: A Report of Two Cases of Coinfection and a Review of the Literature.
Murray J; Lu ZA; Miller K; Meadows A; Totten M; Zhang SX
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983525
[TBL] [Abstract][Full Text] [Related]
11. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus.
Trief D; Gray ST; Jakobiec FA; Durand ML; Fay A; Freitag SK; Lee NG; Lefebvre DR; Holbrook E; Bleier B; Sadow P; Rashid A; Chhabra N; Yoon MK
Br J Ophthalmol; 2016 Feb; 100(2):184-8. PubMed ID: 26112869
[TBL] [Abstract][Full Text] [Related]
13. How We Approach Combination Antifungal Therapy for Invasive Aspergillosis and Mucormycosis in Transplant Recipients.
Haidar G; Singh N
Transplantation; 2018 Nov; 102(11):1815-1823. PubMed ID: 29975240
[TBL] [Abstract][Full Text] [Related]
14. Fungal pathogens and COVID-19.
Singh A; Kaur A; Chowdhary A
Curr Opin Microbiol; 2023 Oct; 75():102365. PubMed ID: 37625261
[TBL] [Abstract][Full Text] [Related]
15. Co-infection of intestinal tuberculosis and mucormycosis in a patient with Down syndrome: a unique case report with literature review.
Pal B; Thirupathaiah K; Badhe BA; Nelamangala Ramakrishnaiah VP; Dutta S; Reddy A; Jain A
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848407
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples.
Rickerts V; Just-Nübling G; Konrad F; Kern J; Lambrecht E; Böhme A; Jacobi V; Bialek R
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):8-13. PubMed ID: 16416267
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary
Ravindra CM; Rajaram M; Madhusmita M; ChToi P; Sneha L
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):495-498. PubMed ID: 34522421
[TBL] [Abstract][Full Text] [Related]
18. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment.
Arndt S; Aschendorff A; Echternach M; Daemmrich TD; Maier W
Eur Arch Otorhinolaryngol; 2009 Jan; 266(1):71-6. PubMed ID: 18470529
[TBL] [Abstract][Full Text] [Related]
20. Invasive, gangrenous mucormycosis of arm: A fatal opportunistic infection in a highly immunocompromised host.
Kanagaraju V; Narayanasamy VK; Sukumaran S; Moorthy U; Sundar VS; Lakshmi SV
Indian J Pathol Microbiol; 2019; 62(4):618-620. PubMed ID: 31611455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
